Iridex CFO Dizon buys $1,350 in IRIX stock

Published 08/09/2025, 16:48
Iridex CFO Dizon buys $1,350 in IRIX stock

Romeo R. Dizon, Chief Financial Officer of Iridex Corp (NASDAQ:IRIX), recently purchased 1,000 shares of the company’s common stock at $1.35 per share, in a transaction totaling $1,350. The stock has since risen to $1.41, with the medical technology company currently valued at approximately $24 million. According to InvestingPro analysis, the company maintains a FAIR financial health score despite facing profitability challenges.

The transaction, which occurred on September 5, 2025, was disclosed in a Form 4 filing with the Securities and Exchange Commission. Following the purchase, Dizon directly owns 55,750 shares of Iridex. InvestingPro analysis reveals 6 additional key insights about IRIX’s financial position and market performance, available in the comprehensive Pro Research Report, which provides deep-dive analysis of over 1,400 US stocks.

In other recent news, IRIDEX Corporation reported its second-quarter earnings for 2025, delivering results that surpassed analysts’ expectations. The company achieved an earnings per share (EPS) of -$0.06, beating the projected -$0.09. Additionally, IRIDEX reported revenue of $13.6 million, exceeding the anticipated $13.1 million. These figures highlight a stronger-than-expected financial performance for the quarter. The earnings announcement was followed by notable market activity, although specific stock price movements are not detailed here. These recent developments reflect positively on IRIDEX’s financial outlook. Analyst firms have not been mentioned regarding any upgrades or downgrades, focusing solely on the company’s earnings and revenue achievements.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.